Samarth Kulkarni
CIK 1682019 · Chief Executive Officer · last filed 2026-06-29
Samarth Kulkarni is a Chief Executive Officer who has filed 123 SEC Form 4 insider transactions across 6 companies since 2017. The most recent filing, for BDTX, was dated Jun 29, 2026. Across all open-market trades the lifetime net is −$65.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $16.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$16.25M
6
123
-$65.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDTX | Director | — | $1.69 | — | $0 | 7 | 2026-06-29 |
| Centessa Pharmaceuticals plc (CNTA) Delisted | Director | — | $40.50 | — | $0 | 5 | 2026-06-24 |
| ORKA | Director | — | $87.84 | — | $0 | 2 | 2026-06-03 |
| CRSP | Chief Executive Officer | 341,123 | $47.64 | $16.25M | -$64.02M | 87 | 2026-03-24 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | — | $2.65 | — | $0 | 4 | 2024-06-20 |
| CRISPR Therapeutics AG (PZRX) Delisted | Chief Executive Officer | 148,560 | — | — | -$1.01M | 7 | 2017-12-26 |
Recent Filings
123 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-29 | BDTX | Grant (A) | — | $0 | EDGAR |
| 2026-06-24 | Centessa Pharmaceuticals plc (CNTA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2026-06-03 | ORKA | Grant (A) | — | $0 | EDGAR |
| 2026-03-24 | CRSP | Mixed | +9,667 | -$468.7K | EDGAR |
| 2026-03-17 | CRSP | Mixed | +10,276 | -$499.4K | EDGAR |
| 2026-03-12 | CRSP | Mixed | +9,452 | -$517.3K | EDGAR |
| 2026-02-20 | CRSP | Mixed | +6,283 | -$366.3K | EDGAR |
| 2026-01-22 | CRSP | Notice (144) | −60,000 | -$3.65M | EDGAR |
| 2026-01-22 | CRSP | Sell (S) | −90,000 | -$5.17M | EDGAR |
| 2026-01-20 | CRSP | Notice (144) | −30,000 | -$1.58M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.